Austin Clinical Research

The trials here

What the 8 trials at this site are about, from their registry records.

Conditions

• Macular degeneration5 trials
• Diabetic eye disease3 trials

Phase

• Phase 23 trials
• Phase 33 trials
• Phase 1/21 trial
• Phase 2/31 trial

Status

• Active, not recruiting4 trials
• Recruiting3 trials
• Completed1 trial

Lead sponsor

• 4D Molecular Therapeutics5 trials
• Janssen Research & Development, LLC2 trials
• AbbVie1 trial

Running trials

• Recruiting

  A Phase 3 Trial for Intravitreal Injection of 4D-150 in Adults With Diabetic Macular Edema (DME).

  NCT07867080· Phase 3· 4D Molecular Therapeutics· Source

  Contact: 4DMT Patient Advocacy

• Recruiting

  Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration

  NCT07064759· Phase 3· 4D Molecular Therapeutics· Source

  Contact: 4DMT Patient Advocacy

• Active, not recruiting

  4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration

  NCT06864988· Phase 3· 4D Molecular Therapeutics· Source

• Recruiting

  A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

  NCT06635148· Phase 2/3· Janssen Research & Development, LLC· Source

• Active, not recruiting

  4D-150 in Patients With Diabetic Macular Edema

  NCT05930561· Phase 2· 4D Molecular Therapeutics· Source

• Active, not recruiting

  Long-Term Follow-Up Study of RGX-314 Administered in the Suprachoroidal Space for Participants With and Without Diabetic Retinopathy

  NCT05296447· Phase 2· AbbVie· Source

• Recruiting

  4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration

  NCT05197270· Phase 1/2· 4D Molecular Therapeutics· Source

  Contact: Ivana Gunderson

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Macular degeneration2 recruiting
• Diabetic eye disease1 recruiting

Closed trials

• Completed

  A Study to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

  NCT05811351· Phase 2· Janssen Research & Development, LLC· Source